Please complete the CAPTCHA to continue
@alzheon.com
✓
3 phones found area 212 and 508
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Martin Tolar, Md, Phd is listed as Founder, President & CEO at Alzheon, Inc. | Founder & Director at Tolion Health, Inc. | Founder at INDRC | Alzheimer’s Disease Research at Tolion Health, Inc., based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at alzheon.com, phone signal with area code 212, 508, and a matched LinkedIn profile for Martin Tolar, Md, Phd.
Martin Tolar, Md, Phd previously worked as Founder & Director at Tolion Health, Inc. and Founder, President & CEO at Alzheon, Inc.. Martin Tolar, Md, Phd holds Executive Management from University Of Michigan - Stephen M. Ross School Of Business.
This section adds company-level context without repeating Martin Tolar, Md, Phd's masked contact details.
AeroLeads found 2 current-domain work email signals for Martin Tolar, Md, Phd. Compare company email patterns before reaching out.
Martin Tolar, MD, PhD, Founder, President & CEO at Alzheon, Inc., Founder & Director at Tolion Health, Inc.Prior to founding Alzheon in 2013, Dr. Tolar has held executive positions in life sciences companies, where he has successfully established and grown new companies, business areas and product opportunities. Dr. Tolar served as President & CEO of Knome, Inc., where he pioneered human genome interpretation systems and services, as President & CEO at NormOxys, Inc., where he built and financed the business for novel cancer therapeutics, and as CSO and CBO at CoMentis, Inc., where he developed the first clinical beta secretase inhibitor platform and negotiated a landmark deal for the program for $1.1 billion with Astellas Pharma in 2008. Dr. Tolar held clinical development and business leadership positions at Pfizer, where he was instrumental in a wide range of business transactions, including acquisition of Rinat Neuroscience for $500 million in 2006, and directed programs through all stages of clinical development.During his academic career, Dr. Tolar served as an Assistant Professor in the Department of Neurology at Yale University School of Medicine, where he focused on movement disorders. Dr. Tolar trained in Neurology at the Boston Medical Center, received a Ph.D. in Neuroscience for his work on the role of apolipoprotein E in Alzheimer’s disease, and published many scientific publications in the area of neuroscience and neurodegenerative disorders. Dr. Tolar received his M.D. from Charles University in Prague, where, as a medical student, he helped organize and lead the Velvet Revolution that toppled the communist regime in the former Czechoslovakia in November 1989.In 2021, Dr. Tolar founded the International Neurodegenerative Disorders Research Center, INDRC, a global institute applying artificial intelligence and machine learning solutions to identify therapeutic interventions for Alzheimer’s disease and other neurodegenerative disorders. He served as the Chairman of the INDRC Executive Board through 2024. Dr. Tolar also serves on business and scientific boards including the Alzheimer’s Drug Discovery Foundation, the Alzheimer Foundation and Advance Healthcare Management Institute.Dr. Tolar was recognized as one of the Top 100 Most Influential People in the world of drug development and manufacture by The Medicine Maker Magazine’s Power Lists for 2016, 2017, 2018 and 2019. In 2021, Dr. Tolar received the Czech Laurels Award from the Czech Chamber of Commerce in recognition of his leadership in Alzheimer disease therapeutics.
Listed skills include Sales Management, Business Strategy, Solution Selling, Key Account Management, and 62 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Tolion Health, Inc. provides preventive, predictive and personalized brain health and longevity guidance based on science and enabled by AI.We utilize novel AI technology to help people at increased risk of dementia maintain brain health and top performance, prevent disability and onset of symptoms by providing personalized life-long preventive and.
Framingham, MA, US
Alzheon, Inc. is a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from Alzheimer’s disease and other neurodegenerative disorders. We are committed to developing innovative medicines by directly addressing the underlying pathology of neurodegeneration.Our lead.
New York, NY, US
The Alzheimer’s Drug Discovery Foundation is non-profit organization whose mission is to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer’s disease, related dementias and cognitive aging. The Foundation raises and awards funds to academic and biotechnology scientists conducting drug discovery research in this field.
The Alzheimer Foundation supports research of Alzheimer disease and other neurodegenerative and brain vascular diseases that lead to cognitive malfunctions and dementia, and strives to improve quality of patient care, extend the framework of care offered, and improve conditions under which it is provided. Foundation enables: a) expansion of diagnostic.
Praha 4, Praha, CZ
Advance Healthcare Management Institute strives to improve the management of health care in the Czech Republic, especially at the management level of organizations, with focus on rational decision-making based on facts and needs of patients and insured, thereby increasing both quality and efficiency of health services. Institute's mission is to provide.
Praha 6, Prague, CZ
The INDRC, International Neurodegenerative Disorders Research Center, is a private, non-profit, global research institute based in Prague, Czech Republic, that for the first time combines biological sciences and medicine with big data and artificial intelligence approaches to study and treat Alzheimer’s disease and other neurodegenerative disorders.The.
Laval, Quebec, CA
Bellus Health is a public development-focused healthcare company concentrating on products that provide innovative health solutions and address critical unmet medical needs. Bellus Health is based in Laval, Quebec and its shares trade under the ticker BLU on the Toronto Stock Exchange.
Cambridge, MA, US
Knome is a leading provider of human genome interpretation systems and services, helping academic, pharmaceutical and clinical clients in two dozen countries identify the genetic basis of disease, tumor growth, drug response and treatment. Company’s big data technologies accelerate and industrialize the process of interpreting whole human genomes.
Hyderabad, Telangana, IN
Suven is a public biopharmaceutical company focused on innovative drug development and commercialization of novel first-in-class or best-in-class therapies for neuropsychiatric, inflammatory and metabolic disorders through the use of GPCR targets. The company is a leading provider of full spectrum services in drug discovery, development and manufacturing.
US
NormOxys is a private biotechnology company founded by Nobel Laureate Jean-Marie Lehn. NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to hypoxic diseased tissues, such as may be present in cancer, cardiovascular diseases, anemia, Alzheimer's disease, stroke and.
South San Francisco, CA, US
CoMentis is a private biotechnology company engaged in the discovery and development of small molecule drugs to treat Alzheimer's disease, age-related macular degeneration and cognitive disorders utilizing two versatile technology platforms: (i) aspartic protease inhibitors for Alzheimer's disease and infectious disorders; and (ii) nicotinic acetylcholine.
Quick answers generated from the profile data available on this page.
Martin Tolar, Md, Phd works for Tolion Health, Inc..
Martin Tolar, Md, Phd is listed as Founder, President & CEO at Alzheon, Inc. | Founder & Director at Tolion Health, Inc. | Founder at INDRC | Alzheimer’s Disease Research at Tolion Health, Inc..
AeroLeads has found 2 work email signals at @alzheon.com for Martin Tolar, Md, Phd at Tolion Health, Inc..
AeroLeads has found 3 phone signal(s) with area code 212, 508 for Martin Tolar, Md, Phd at Tolion Health, Inc..
Martin Tolar, Md, Phd is based in Cambridge, Massachusetts, United States while working with Tolion Health, Inc..
Martin Tolar, Md, Phd has worked for Tolion Health, Inc., Alzheon, Inc., Alzheimer'S Drug Discovery Foundation, The Alzheimer Foundation, and Advance Healthcare Management Institute.
You can use AeroLeads to view verified contact signals for Martin Tolar, Md, Phd at Tolion Health, Inc., including work email, phone, and LinkedIn data when available.
Martin Tolar, Md, Phd holds Executive Management from University Of Michigan - Stephen M. Ross School Of Business.
Martin Tolar, Md, Phd is listed with skills including Sales Management, Business Strategy, Solution Selling, Key Account Management, Product Marketing, Marketing Strategy, Cloud Computing, and Business Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts